Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Teixeira, H. Dabó, I. Gomes, A. Marques (Porto, Portugal). C-reactive protein in pulmonary tuberculosis-correlation with extent and severity of the disease. Eur Respir J 2012; 40: Suppl. 56, 2597

Member's Comments

No comment yet.

Related content which might interest you: C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Source: Eur Respir J 2006; 27: 902-907 Year: 2006 The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 363s Year: 2007 Factors affecting C-reactive protein levels in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Differences in cellular expression of C-reactive protein and serum amyloid A in lung tissue in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 C-reactive protein and serum amyloid A overexpression in lung tissues of chronic obstructive pulmonary disease patients Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 C-reactive protein (CRP) as a risk marker in COPD patients with ischaemic heart disease Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Genetically elevated C-reactive protein and chronic obstructive pulmonary disease Source: Annual Congress 2009 - Environmental and genetic risk factors for asthma and COPD Year: 2009 Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Source: Eur Respir J 2008; 32: 1451-1457 Year: 2008 Is there a relationship between severity of COPD and C-reactive protein (CRP) levels? Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006 Body composition and plasma levels of inflammatory biomarkers in COPD Source: Eur Respir J 2010; 36: 1027-1033 Year: 2010 C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Evaluation of neutrophil lymphocyte ratio and C-reactive protein values in the treatment of acute chronic obstructive pulmonary disease exacerbation according to endotype Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 C-reactive protein in pulmonary TB Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009 Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Coexisting chronic diseases in COPD – cause of elevated level of C-reactive protein? Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Highly sensitive C-reactive protein: is it a predictor of airway disease severity in mustard lung patients? Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 C-reactive protein levels in COPD according to clinical parameters, smoking behavior and pulmonary hypertension Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005